Search the Newsreel

Regents Gate Capital LLP Has $24.71 Million Stock Position in IDEX Corporation $IEX

Regents Gate Capital LLP significantly increased its stake in IDEX Corporation (NYSE:IEX) by 59.9% in the first quarter, now holding 130,389 shares valued at $24.7 million. This move follows IDEX's strong quarterly financial performance, exceeding EPS and revenue expectations, and providing optimistic guidance for …

Financiere des Professionnels Fonds d investissement inc. Purchases Shares of 11,100 IDEX Corporation $IEX

Financiere des Professionnels Fonds d investissement inc. initiated a new position in IDEX Corporation by purchasing 11,100 shares valued at approximately $2.1 million during the first quarter. Several analysts have upgraded their ratings and raised price targets for IDEX, contributing to a "Moderate Buy" …

IDEX Corporation stock holds steady on recent results

IDEX Corporation's stock remains stable due to its solid 2025 financial results, including $3.28 billion in revenue, a 27.7% adjusted EBITDA margin, and $8.10 adjusted EPS. These figures highlight the company's consistent profitability and operational efficiency, especially given its diversified industrial and specialized fluid …

IDEX Corp. stock outperforms competitors despite losses on the day

Shares of IDEX Corp. (IEX) fell 1.76% to $224.94 on Friday, breaking a three-day winning streak, despite a broader market decline with the S&P 500 and Dow Jones Industrial Average also posting losses. The stock's performance is noted as outperforming competitors despite the daily …

IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.50% on Friday, closing at $567.44, amidst a general market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. This dip ended a two-day winning streak for the company's shares. The underperformance was noted …

Is IDEX (IEX) Outperforming Other Industrial Products Stocks This Year?

Idex (IEX) has significantly outperformed its peers in the Industrial Products sector and its specific industry group this year, with a year-to-date gain of 28.7% compared to the sector's 16.9% average. The company currently holds a Zacks Rank of #2 (Buy), indicating an improving …

RBC Capital Maintains IDEX Corp(IEX.US) With Buy Rating, Raises Target Price to $261

RBC Capital has reiterated its Buy rating on IDEX Corp (IEX.US) and increased its price target to $261. This indicates continued confidence in the company's performance and future prospects from the analyst firm.

IDEXX Laboratories stock trades near record levels as companion animal diagnostics drive growth

IDEXX Laboratories stock is trading near record levels, driven by strong demand for companion animal diagnostics and software services for veterinary practices. The company reported double-digit revenue growth and improved operating margins, primarily from its companion animal group, which accounts for over 85% of …

IDEXX Laboratories (IDXX) Could Be 19% Undervalued After Stifel Flags Better Pet Health Trends

Stifel's recent commentary suggests that IDEXX Laboratories (IDXX) could be significantly undervalued, with an estimated fair value of $709.14 compared to its current price of $576.07, representing a 19% undervaluation. This assessment is based on improving confidence among U.S. veterinarians regarding companion animal health …

IDEX stock trades steadily as recent earnings highlight margin resilience

IDEX Corporation's stock shows steady performance on Nasdaq, supported by recent quarterly figures demonstrating expanding margins and strong cash generation from its fluid and metering technologies. The company's revenue and operating income have grown year-over-year, attributed to pricing discipline, cost control, and a favorable …

IEX5186761 Bond Risk Profile

This page provides a risk profile for the IEX5186761 bond, issued by IDEX Corporation with a 2.625% coupon maturing on June 15, 2031. It offers an overview of the bond's coupon, redemption details, and risks, including a credit risk assessment with key metrics. Users …

How Idex Corporation (IEX) Affects Rotational Strategy Timing

This article analyzes Idex Corporation (IEX) using AI models, outlining its influence on rotational strategy timing. It identifies a near-term strong sentiment, mid-term neutrality, and long-term positive bias, along with specific trading strategies for different risk profiles. The analysis highlights a significant risk-reward short …

IRIDEX CORP (IRIX) CEO awarded RSUs, PSUs and stock options

IRIDEX CORP President and CEO Patrick Mercer has been granted significant equity awards, including 100,000 restricted stock units (RSUs), 100,000 performance RSUs, and stock options for 200,000 shares. These

A28WWN Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the A28WWN bond issued by IDEX Corporation, detailing its interest rate and payment schedule. The bond has a current coupon rate of 3.00%, with the next payment scheduled for November 2, 2026. It highlights the availability of …

A28WWN Bond Risk Profile

This article provides a risk profile for the IDEX Corporation 3.0% 01-MAY-2030 A28WWN bond. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help investors evaluate the bond's reliability. The platform also offers access to exclusive …

US45167RAH7 Bond Profile — Key Metrics

This article provides a bond profile for IDEX Corporation's 2.625% bond maturing on June 15, 2031, with the ticker US45167RAH7. It details key facts such as the issuer, issue and maturity dates, outstanding amount, face value, coupon rate, and minimum denomination. The profile also …

IDEXX Laboratories Earnings Preview: What to Expect

IDEXX Laboratories Stock: $876 Target Backed by Cancer Dx Adoption Across 7,500 Practices

IDEX’s 96% range position tests a split machinery backdrop on average volume

IDEX closed at $227.20 after a 1.0% week, keeping its 26-week Trend Signal active, but participation stayed ordinary and industry Relative Strength remains uneven.

Why IDEXX Laboratories Stock Looks Undervalued After Raising Its 2026 EPS Outlook to $15

IRIX Q1 2026 Earnings: EPS Beats Estimates by 58%, Stock Rises Nearly 3% - Guidance Accuracy Score

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

IRIDEX Corporation Q1 2026 Earnings Call Summary

Iridex Reports First Quarter 2026 Financial Results

IDEXX Laboratories, Inc. Q1 2026 Earnings Call Summary

Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates

Here's How IDEXX Laboratories Is Placed Ahead of Q1 Earnings

What Analyst Projections for Key Metrics Reveal About Idexx (IDXX) Q1 Earnings

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

What You Need to Know Ahead of IDEXX Laboratories' Earnings Release

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Stocks making the biggest moves midday: Disney, Robinhood, Palantir, IDEXX Laboratories & more

IDEXX Laboratories, Inc.: Konsensus der Analysten und Kursziel | 888210 | US45168D1046

IDEXX Laboratories Aktie • 888210 • US45168D1046